SAB Biotherapeutics SABSW Stock
0.03 USD
{{ price }}
150.833310%
{{change_pct}}%
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
0 USD
LOW - HIGH [24H]
0.03
-
0.03 USD
VOLUME [24H]
1.5K USD
{{ volume }}
P/E Ratio
0.10
Earnings per share
0.29 USD
SAB Biotherapeutics Price Chart
SAB Biotherapeutics SABSW Financial and Trading Overview
| SAB Biotherapeutics stock price | 0.03 USD |
| Previous Close | 0.13 USD |
| Open | 0.11 USD |
| Bid | 0.11 USD x 1000 |
| Ask | 0.13 USD x 1200 |
| Day's Range | 0.09 - 0.15 USD |
| 52 Week Range | 0.09 - 0.15 USD |
| Volume | 7.93K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.47945207 |
| EPS (TTM) | 0.29 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SABSW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | 0.47945207 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
SAB Biotherapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.09 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
SABSW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For SAB Biotherapeutics Stock
What is a current SABSW stock price?
SAB Biotherapeutics SABSW stock price today per share is 0.03 USD.
How to purchase SAB Biotherapeutics stock?
You can buy SABSW shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SAB Biotherapeutics?
The stock symbol or ticker of SAB Biotherapeutics is SABSW.
How many shares does SAB Biotherapeutics have in circulation?
The max supply of SAB Biotherapeutics shares is 0.
What is SAB Biotherapeutics Price to Earnings Ratio (PE Ratio)?
SAB Biotherapeutics PE Ratio is 0.10308219 now.
What was SAB Biotherapeutics earnings per share over the trailing 12 months (TTM)?
SAB Biotherapeutics EPS is 0.29 USD over the trailing 12 months.